Search research articles
Contact Us
Filters
Showing results (61-70 of 76) with videos related to
Page
of 8
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 20, 2000
An overview of the 1999 US Public Health Service/Infectious Diseases Society of America guidelines for preventing opportunistic infections in human immunodeficiency virus-infected persons
J E Kaplan, H Masur, K K Holmes, et al.
Antimicrobial Agents and Chemotherapy
|
September 15, 2001
Pharmacokinetic and pharmacodynamic modeling of anidulafungin (LY303366): reappraisal of its efficacy in neutropenic animal models of opportunistic mycoses using optimal plasma sampling
A H Groll, D Mickiene, R Petraitiene, et al.
Antimicrobial Agents and Chemotherapy
|
February 27, 1999
A multiple drug interaction study of stavudine with agents for opportunistic infections in human immunodeficiency virus-infected patients
S C Piscitelli, G Kelly, R E Walker, et al.
Antimicrobial Agents and Chemotherapy
|
September 3, 1999
Pharmacokinetics and safety of high-dose and extended-interval regimens of levofloxacin in human immunodeficiency virus-infected patients
S C Piscitelli, K Spooner, B Baird, et al.
The Journal of Antimicrobial Chemotherapy
|
June 25, 1999
Liposomal nystatin against experimental pulmonary aspergillosis in persistently neutropenic rabbits: efficacy, safety and non-compartmental pharmacokinetics
A H Groll, C E Gonzalez, N Giri, et al.
Antimicrobial Agents and Chemotherapy
|
March 18, 2000
Compartmental pharmacokinetics and tissue distribution of multilamellar liposomal nystatin in rabbits
A H Groll, D Mickiene, K Werner, et al.
Antimicrobial Agents and Chemotherapy
|
February 13, 2001
Dosage-dependent antifungal efficacy of V-echinocandin (LY303366) against experimental fluconazole-resistant oropharyngeal and esophageal candidiasis
V Petraitis, R Petraitiene, A H Groll, et al.
Antimicrobial Agents and Chemotherapy
|
June 1, 1994
Itraconazole for experimental pulmonary aspergillosis: comparison with amphotericin B, interaction with cyclosporin A, and correlation between therapeutic response and itraconazole concentrations in plasma
J Berenguer, N M Ali, M C Allende, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 1, 1995
Pharmacokinetics of orally administered carboxyamido-triazole, an inhibitor of calcium-mediated signal transduction
W D Figg, K A Cole, E Reed, et al.
Pharmacotherapy
|
December 28, 1999
Atovaquone suspension in HIV-infected volunteers: pharmacokinetics, pharmacodynamics, and TMP-SMX interaction study
J Falloon, S Sargent, S C Piscitelli, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 76) with videos related to
Sort By:
Page
of 8
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 20, 2000
An overview of the 1999 US Public Health Service/Infectious Diseases Society of America guidelines for preventing opportunistic infections in human immunodeficiency virus-infected persons
J E Kaplan, H Masur, K K Holmes, et al.
Antimicrobial Agents and Chemotherapy
|
September 15, 2001
Pharmacokinetic and pharmacodynamic modeling of anidulafungin (LY303366): reappraisal of its efficacy in neutropenic animal models of opportunistic mycoses using optimal plasma sampling
A H Groll, D Mickiene, R Petraitiene, et al.
Antimicrobial Agents and Chemotherapy
|
February 27, 1999
A multiple drug interaction study of stavudine with agents for opportunistic infections in human immunodeficiency virus-infected patients
S C Piscitelli, G Kelly, R E Walker, et al.
Antimicrobial Agents and Chemotherapy
|
September 3, 1999
Pharmacokinetics and safety of high-dose and extended-interval regimens of levofloxacin in human immunodeficiency virus-infected patients
S C Piscitelli, K Spooner, B Baird, et al.
The Journal of Antimicrobial Chemotherapy
|
June 25, 1999
Liposomal nystatin against experimental pulmonary aspergillosis in persistently neutropenic rabbits: efficacy, safety and non-compartmental pharmacokinetics
A H Groll, C E Gonzalez, N Giri, et al.
Antimicrobial Agents and Chemotherapy
|
March 18, 2000
Compartmental pharmacokinetics and tissue distribution of multilamellar liposomal nystatin in rabbits
A H Groll, D Mickiene, K Werner, et al.
Antimicrobial Agents and Chemotherapy
|
February 13, 2001
Dosage-dependent antifungal efficacy of V-echinocandin (LY303366) against experimental fluconazole-resistant oropharyngeal and esophageal candidiasis
V Petraitis, R Petraitiene, A H Groll, et al.
Antimicrobial Agents and Chemotherapy
|
June 1, 1994
Itraconazole for experimental pulmonary aspergillosis: comparison with amphotericin B, interaction with cyclosporin A, and correlation between therapeutic response and itraconazole concentrations in plasma
J Berenguer, N M Ali, M C Allende, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 1, 1995
Pharmacokinetics of orally administered carboxyamido-triazole, an inhibitor of calcium-mediated signal transduction
W D Figg, K A Cole, E Reed, et al.
Pharmacotherapy
|
December 28, 1999
Atovaquone suspension in HIV-infected volunteers: pharmacokinetics, pharmacodynamics, and TMP-SMX interaction study
J Falloon, S Sargent, S C Piscitelli, et al.
Page
of 8